Replies to post #300938 on Anavex Life Sciences Corp (AVXL)

[boi568]

I don't think that Missling has a basket trial in place -- yet. I think he has been arranging the pieces so that he can weave the various trials together as an exploration of Sigma1 receptor function. If these progress as planned (and with a few minor approvals en route), he then can seek a broad CNS platform basket approval without having to undertake multiple, full blown Phase 3 trials in each indication.